Related Experiment Video
Updated: Jun 9, 2026
A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies
Published on: September 23, 2014
[TA90--new neoplastic marker]
Sławomir Rudzki1, Jakub Gołyski, Paweł Bronikowski
1Uniwersytet Medyczny w Lublinie, I Katedra i Klinika Chirurgii Ogólnej, Transplantacyjnej i Leczenia Zywieniowego.
Abstract:
TA90 is a glycoprotein, occurring on the cell surface of many types of cancer. Determination of its concentration in human serum appears to be a good screening test in the direction of many cancers, and also can act as a monitoring index of disease, particularly in respect of melanoma. Further clinical studies are necessary in order to obtain accurate data on the TA90, and after that its determination might be made to everyday clinical practice in oncology.
